<< 1 2 3 4 5  ... >> 



Researchers receive grant to study use of natural compounds in triple-negative breast cancer prevention
Published: 10/31/2017

Researchers at The University of Kansas Cancer Center will explore triple-negative breast cancer prevention therapies using natural compounds thanks to a grant for approximately $1.5 million in funding by the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP).

Monday Night Football Announcement: $200,000 Research Grant to Cancer Center Researcher
Published: 10/30/2017

Mary Markiewicz, Ph.D., assistant professor at the University of Kansas Medical Center in the Department of Microbiology, Molecular Genetics and Immunology and a researcher with KU Cancer Center, will receive the grant, made possible by a unique partnership with the Kansas City Chiefs, ESPN, the V Foundation For Cancer Research and The University of Kansas Health System.

The University of Kansas Cancer Center Is Chosen to Be One of the First Sites in the Country to Have Newly Approved Immunotherapy for Lymphoma
Published: 10/26/2017

The University of Kansas Cancer Center, the only National Cancer Institute designated cancer center in the region, will be offering the first-ever FDA-approved CAR T cell therapy for non-Hodgkin lymphoma patients meeting certain criteria.

CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer
Published: 10/11/2017

CicloMed LLC announced that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was cleared by the U.S. Food and Drug Administration to begin human clinical trials. With this clearance, CicloMed plans to initiate the first-in-human safety trial in patients with advanced solid tumor cancers as soon as possible at several centers, including The University of Kansas Cancer Center.

Researcher received grant from Susan G. Komen
Published: 10/4/2017

Susan G. Komen announced that it will be awarding Danny Welch, Ph.D., $300,000 to advance research on metastatic breast cancer. Welch is studying the role of genes that suppress the ability of breast cancer cells to spread to other parts of the body (metastasis).

<< 1 2 3 4 5  ... >> 

News


Browse by Year
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Expert Care

find a doctor

Named Among US News & World Reports Best Hospitals for Cancer care 2017-18

Request an Appointment

913-588-1227


Toll Free

844-323-1227


Clinical Trials

Clinical trials can give you access to potentially effective new drugs, therapies and diagnostic tools in research.

Let us match you to an open trial. Contact our clinical trials nurse navigator, 913-945-7552.